The ROE as of November 2024 (TTM) for ERYTECH Pharma S.A. (ERYP) is 6.80%

According to ERYTECH Pharma S.A.’s latest financial reports and current stock price. The company's current ROE is 6.80%. This represents a change of -63.17% compared to the average of 18.45% of the last 4 quarters.

ERYTECH Pharma S.A. (ERYP) Historical ROE (quarterly & annually)

How has ERYP ROE performed in the past?

The mean historical ROE of ERYTECH Pharma S.A. over the last ten years is -80.86%. The current 6.80% ROE has changed -108.40% with respect to the historical average. Over the past ten years (40 quarters), ERYP's ROE was at its highest in in the June 2022 quarter at 48.52%. The ROE was at its lowest in in the December 2020 quarter at -74.41%.

ERYTECH Pharma S.A. (ERYP) ROE by Quarter and Year

Discovering the peaks and valleys of ERYTECH Pharma S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ERYTECH Pharma S.A. (ERYP) Average ROE

How has ERYP ROE performed in the past?

The current ROE of ERYTECH Pharma S.A. (ERYP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ERYTECH Pharma S.A. (ERYP) ROE vs. Peers

How is ERYP’s ROE compared to its peers?

ERYTECH Pharma S.A.’s ROE is less than Genfit S.A. (22.12%), greater than Cyteir Therapeutics, Inc. (-23.13%), greater than Eliem Therapeutics, Inc. (-47.03%), greater than HCW Biologics Inc. (-385.90%), greater than Aptorum Group Limited (-12.10%), greater than Surrozen, Inc. (-178.66%), less than Unicycive Therapeutics, Inc. (294.74%), less than Armata Pharmaceuticals, Inc. (182.35%), less than Addex Therapeutics Ltd (105.53%), greater than Aceragen, Inc. (-46.48%), greater than Soligenix, Inc. (-256.63%), greater than Avenue Therapeutics, Inc. (-749.10%), less than Molecular Partners AG (0%), greater than XORTX Therapeutics Inc. (-33.08%), greater than Nutriband Inc. (-36.97%), greater than Ikena Oncology, Inc. (-76.31%), greater than Enochian Biosciences, Inc. (-42.81%), greater than Exicure, Inc. (-47.54%), greater than null (-288.03%),

Build a custom stock screener for ERYTECH Pharma S.A. (ERYP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ERYTECH Pharma S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ERYTECH Pharma S.A. (ERYP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ERYTECH Pharma S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.